Table 4 Correlation between DKK2 expression and clinicopathological features in 96 NSCLC patients
Parameters | Group | N | Expression of DKK2 | P value | |
|---|---|---|---|---|---|
Low, n (%) | High, n (%) | ||||
Age (years) | ≤ 58 | 47 | 25 (53.19) | 22 (46.81) | 0.3110 |
> 58 | 49 | 21 (42.86) | 28 (57.14) | ||
Gender | Female | 48 | 20 (41.67) | 28 (58.33) | 0.2203 |
Male | 48 | 26 (54.17) | 22 (45.83) | ||
Tumor size (cm) | < 3 | 45 | 19 (42.22) | 26 (57.78) | 0.2941 |
≥ 3 | 51 | 27 (52.94) | 24 (47.06) | ||
TNM stage | I–II | 49 | 18 (36.73) | 31 (63.27) | 0.0042 |
III–IV | 47 | 31 (65.96) | 16 (34.04) | ||
Smoking history | Yes | 53 | 22 (41.51) | 31 (58.49) | 0.0.2422 |
No | 43 | 23 (53.49) | 20 (46.51) | ||
Lymph node metastasis | Yes | 50 | 33 (66.00) | 17 (34.00) | 0.0011 |
No | 46 | 15 (32.61) | 31 (67.39) | ||
Differentiation | Well/moderate | 49 | 12 (24.49) | 37 (75.51) | 0.0039 |
Poor | 47 | 25 (53.19) | 22 (46.81) | ||